YborBio Consulting.
Biotech solutions. Data-driven insights.
YborBio Consulting.
Biotech solutions. Data-driven insights.
YborBio Consulting.
Biotech solutions. Data-driven insights.
YborBio Consulting partners with biotechnology teams to solve complex scientific and market challenges. Focused on trustworthy, data-driven insight, our mission is to elevate your success at every stage of the biotech innovation pipeline.
We blend deep scientific expertise with strategic vision to ensure precise guidance, whether you need regulatory clarity, scientific reviews, or business intelligence. With particular expertise in RNA therapeutics, precision medicine, and orphan diseases, YborBio is committed to supporting early-stage biotech companies to advance their technologies and bring transformative innovations closer to patients.
Flexible, independent, and reliable, YborBio delivers results tailored to your unique needs.
About the Firm
YborBio Consulting partners with biotechnology teams to solve complex scientific and market challenges. Focused on trustworthy, data-driven insight, our mission is to elevate your success at every stage of the biotech innovation pipeline.
We blend deep scientific expertise with strategic vision to ensure precise guidance, whether you need regulatory clarity, scientific reviews, or business intelligence. With particular expertise in RNA therapeutics, precision medicine, and orphan diseases, YborBio is committed to supporting early-stage biotech companies to advance their technologies and bring transformative innovations closer to patients.
Flexible, independent, and reliable, YborBio delivers results tailored to your unique needs.
About the Firm
YborBio Consulting partners with biotechnology teams to solve complex scientific and market challenges. Focused on trustworthy, data-driven insight, our mission is to elevate your success at every stage of the biotech innovation pipeline.
We blend deep scientific expertise with strategic vision to ensure precise guidance, whether you need regulatory clarity, scientific reviews, or business intelligence. With particular expertise in RNA therapeutics, precision medicine, and orphan diseases, YborBio is committed to supporting early-stage biotech companies to advance their technologies and bring transformative innovations closer to patients.
Flexible, independent, and reliable, YborBio delivers results tailored to your unique needs.
About the Firm
Strategy.
Data-driven scientific & business intelligence for accelerated innovation.
Services
Regulation.
Regulatory, safety, and clinical guidance.
Finance.
Pricing, reimbursement, and financial modelling expertise.
Strategy.
Data-driven scientific & business intelligence for accelerated innovation.
Services
Regulation.
Regulatory, safety, and clinical guidance.
Finance.
Pricing, reimbursement, and financial modelling expertise.
Strategy.
Data-driven scientific & business intelligence for accelerated innovation.
Services
Regulation.
Regulatory, safety, and clinical guidance.
Finance.
Pricing, reimbursement, and financial modelling expertise.
Our Latest Works
Explore snapshots of YborBio deliverables, such as regulatory landscape reports, competitive analyses, and modality safety assessments. These highlight our commitment to quality insights tailored for the biotech industry.
Oligonucletoide Therapeutics: 2025 Safety Report
Oligonucletoide Therapeutics: 2025 Landscape Report
Oligonucletoide Therapeutics: 2025 Safety Report
Our Latest Works
Explore snapshots of YborBio deliverables, such as regulatory landscape reports, competitive analyses, and modality safety assessments. These highlight our commitment to quality insights tailored for the biotech industry.
Oligonucletoide Therapeutics: 2025 Safety Report
Oligonucletoide Therapeutics: 2025 Landscape Report
Oligonucletoide Therapeutics: 2025 Safety Report
Our Latest Works
Explore snapshots of YborBio deliverables, such as regulatory landscape reports, competitive analyses, and modality safety assessments. These highlight our commitment to quality insights tailored for the biotech industry.
Oligonucletoide Therapeutics: 2025 Safety Report
Oligonucletoide Therapeutics: 2025 Landscape Report
Oligonucletoide Therapeutics: 2025 Safety Report
Nicolas Roby, PhD
Founder
About the Founder
Nicolas Roby is a life science consultant with extensive cross-functional experience spanning academic research, regulatory strategy, and business insights for early-stage biotech companies. He specializes in leveraging multimodal data aggregation to design tailored datasets that enable smarter decision-making and accelerate innovation.
Holding a PhD in Cell & Molecular Biology, and enrolled in a MSc in Pharmaceutical Management from ESCP Business School, Nicolas delivers client-focused solutions rooted in both science and business needs. Nicolas is based in Paris, France, serving clients globally.
© 2025
All Rights Reserved
Nicolas Roby, PhD
Founder
About the Founder
Nicolas Roby is a life science consultant with extensive cross-functional experience spanning academic research, regulatory strategy, and business insights for early-stage biotech companies. He specializes in leveraging multimodal data aggregation to design tailored datasets that enable smarter decision-making and accelerate innovation.
Holding a PhD in Cell & Molecular Biology, and enrolled in a MSc in Pharmaceutical Management from ESCP Business School, Nicolas delivers client-focused solutions rooted in both science and business needs. Nicolas is based in Paris, France, serving clients globally.
© 2025
All Rights Reserved
Nicolas Roby, PhD
Founder